Results for “ ”

Entry Author Date Location
Spring Bank Pharma Ends Hepatitis B Work After Death in Clinical Trial 01/29/20 Boston
Agenda and Speakers Announced for Xcelerating Life Sciences San Diego 01/29/20 National
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus 01/29/20 Boston
Histogen, Timber Pharma Plan Reverse Mergers to Join Public Markets 01/28/20 San Diego
Third Time’s the Charm as Acceleron Drug Shows Early Promise in PAH 01/28/20 Boston
BioIntelliSense Debuts “Sticker” Sensor to Capture Patient Data Remotely 01/28/20 Boulder/Denver
Passage Bio Appoints Deerfield Management’s Bruce Goldsmith as CEO 01/28/20 New York
Advanced Therapies Are Reshaping Biopharma R&D: KPMG Report 01/28/20 National
Flagship Adds Fertility-Focused Ohana Biosciences to Biotech Family 01/27/20 Boston
Quench Bio Springs From Atlas With $50M for a New Take on Inflammation 01/27/20 Boston
Life Sciences IPOs Target Collective Raise of More Than $600M This Week 01/27/20 National
Allergan Offloads Two Drugs to Secure Approval of Merger With AbbVie 01/27/20 National
Beam Therapeutics Promotes Giuseppe Ciaramella to President 01/24/20 Boston
Acceleron Pharma Exec Quisel Is Leaving to Join a Biotech Startup 01/24/20 Boston
Bio Roundup: Coronavirus Concerns, Sarepta’s CRL, Eye Drug OK’d & More 01/24/20 National
Epizyme’s Soft Tissue Cancer Drug Granted Speedy FDA Approval 01/23/20 Boston
Kura Oncology Chief Medical Officer Plans to Step Down Next Month 01/23/20 San Diego
Poxel Picks Sigilon’s Moller for Chief Scientific Officer Post 01/23/20 Boston
Krystal Biotech Names Genzyme’s Chien Chief Commercial Officer 01/23/20 National
After AstraZeneca, Osbourn Reflects on Roles at CAT & MedImmune 01/23/20 National
FDA Flags Risk of Infection, Kidney Damage for Sarepta Duchenne Drugs 01/22/20 Boston
Healthcare Investment Trends: Where Will the Money Flow in 2020? 01/22/20 New York
Horizon Gets Early FDA OK for First Thyroid Eye Disease Treatment 01/22/20 National
Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits 01/22/20 New York
CEOs of Women’s Health Companies Fight to Open Investment Floodgates 01/22/20 San Diego
After Ending Cancer Drug Program, Halozyme Predicts Profits in 2020 01/21/20 San Diego
Of Science and Sea Urchins: Researchers Plumb Oceans for Biological Insights 01/21/20 Boston
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers 01/17/20 San Francisco
Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More 01/17/20 National
BioCryst Pharma Promotes Charles Gayer to Chief Commercial Officer 01/16/20 Raleigh Durham
Page 1 of 2120 next page »